Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls – A randomized placebo-controlled crossover trial
In conclusion, we suggest that recommendations for caffeine abstinence for patients with PD should be based on higher doses and ideally on individual assessments.
Authors
- Andreas Frick (ORCID: https://orcid.org/0000-0003-2516-9075)
- Johannes Björkstrand (ORCID: https://orcid.org/0000-0002-1786-1064)
- Malin Gingnell (ORCID: https://orcid.org/0000-0001-5310-6843)
- Johan R. Vegelius (ORCID: https://orcid.org/0000-0002-0497-0659)
- Johanna M. Hoppe (ORCID: https://orcid.org/0000-0003-1214-2586)
- Lisa Klevebrant
Institutions
- Uppsala University (SE)
- Lund University (SE)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1177/02698811251344692
- Primary Topic
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Åke Wiberg Stiftelse
- Hjärnfonden
- Vetenskapsrådet
- Kjell och Märta Beijers Stiftelse